---
title: GemPharmatech vs LIDE Biotech
slug_a: gempharmatech
slug_b: lide-biotech
site: cro
review_signal_gate: closed
canonical_path: /compare/gempharmatech/lide-biotech
---

# GemPharmatech vs LIDE Biotech

Side-by-side profile data from each company listing on this directory.

## GemPharmatech

- Profile: [/companies/gempharmatech](/companies/gempharmatech)

GemPharmatech — GemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.

Services: 7. Modalities: 1. Indications: 7. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Target Identification & Validation
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- Specialized & Large-Animal Models

### Modalities

- Biologics (Monoclonal Antibodies)

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease

### Phases

- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## LIDE Biotech

- Profile: [/companies/lide-biotech](/companies/lide-biotech)

LIDE Biotech — Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.

Services: 10. Modalities: 2. Indications: 2. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (10).

### Services

- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- Specialized & Large-Animal Models
- Biomarker Assays
- Immunology & Inflammation Services
- Oncology Specialty Services
- Genomics & Sequencing Services
- Proteomics Services

### Modalities

- Antibody-Drug Conjugate (ADC)
- Cell Therapy

### Indications

- Oncology
- Immunology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)